用户经验和静脉效果:在结节和肝脏出血模型中对商业药物的比较分析
Kyle Patterson1,2, Adelle M Dagher1,2, Meredith Lackie1,2
1Battlefield Shock and Organ Support Laboratory, The Uniformed Services University of the Health Sciences, Bethesda, Maryland, United States of America.
PloS one
|August 29, 2025
概括
在猪模型中,五种商用静止剂有效控制了结节和腹腔内出血,不论应用者有多久的经验. 所有药物都表现出相似的疗效,没有观察到重出血率或生存率的显著差异.
科学领域:
- 创伤和紧急医疗
- 手术血液静止
- 伤口管理
背景情况:
- 在战斗中导致可预防死亡的主要原因是出血.
- 在长时间的疏散过程中,对非压缩性干部和结节出血的管理至关重要.
- 局部止血剂为快速控制出血提供了潜在的解决方案.
研究的目的:
- 评估五种商用局部止血剂的疗效.
- 在凝血病的条件下评估药物的效果.
- 检查应用器经验对止血剂有效性的影响.
主要方法:
- 在随机试验中使用了60只约克郡猪.
- 模型包括5毫米的股骨动脉切割和6厘米的肝脏撕裂.
- 经验丰富和未经验丰富的使用者在50%的血液稀释后使用药物.
- 动物在60分钟内被监测到是否会再次出血.
主要成果:
- 在五种药物 (Combat Gauze,Celox Rapid,ChitoSAM 100,EVARREST®纤维素密封剂贴片,X- Stat 30) 中,没有发现重出血率或生存率的显著差异.
- 对于大多数药物,应用者经验没有显著影响血液静止或再出血率.
- 对于新手使用者来说,ChitoSAM 100需要更多的应用来控制结点出血.
结论:
- 所有五种测试的止血剂在控制结节和腹腔内出血方面都表现出相似的有效性.
- 应用者经验没有改变药物的整体有效性.
- 这些带有望在重症监护机构快速控制出血.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
889
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
889
Introduction to Hemostasis
8.9K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
8.9K
Extrinsic and Intrinsic Pathways of Hemostasis
9.2K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
9.2K


